$ADNT

Carlin Peter sold $151K of ADNT

Carlin Peter sold 7,843 shares of Adient plc (ADNT) at $19.25 ($0.15M total) on 2026-09-02.

Original reporting
SEC EDGAR · Carlin Peter
Published Sep 4, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ADNT
Bearish
medium confidence
Mentioned
$ADNT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ADNTBearishLow
01

Why it matters

The director's sale may be interpreted as a lack of confidence, but the amount is relatively small.

02

Market read

Minor insider sale; limited impact on broader market.

03

Timing

Filed Sep 4 2026

Relevance 4/10Novelty 4/10Timing: Filed Sep 4 2026

Background

SEC Form 4 filing discloses insider transactions.

Company-level read

Ticker impact

$ADNTBearishMedium confidence
Context

Director Carlin Peter sold 7,843 shares of ADNT for $150,978 on Sep 2, 2026.

Expected impact

Potential slight downward pressure on ADNT price.

Evidence & confidence

The sale size is modest ($151K) but involves a director, which can influence short-term sentiment.

Key entities

  • Adient plc

    Automotive seating manufacturer listed on NYSE (ADNT).

  • Carlin Peter

    Director of Adient plc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ADNTMedAI 8/10

Adient FY26 slides: cash flow strong despite Q4 earnings miss

Adient (ADNT) reported Q4 adjusted earnings of $0.52 per share, missing estimates of $0.66, while full-year revenue grew 4% to $15.2B. Adjusted EBITDA remained flat at $884M, with margins compressing. Free cash flow was $222M, including $60M in timing-related benefits. The stock rose 1.83% post-earnings. Management guided for EBITDA growth in FY2027 despite expected revenue decline.

$ADNTMed

Adient: Fiscal Q4 Earnings Snapshot

Adient PLC (ADNT) reported a fiscal Q4 loss of $47M, or 62 cents per share, missing estimates of 63 cents per share. Revenue was $3.73B, beating forecasts of $3.59B. The company expects full-year revenue between $14.8B and $15B. Shares are down 12% YTD and 30% over the past year.

$ADNTHighAI 8/10

Adient announces increased share repurchase authorization and adoption of tax benefits preservation plan

Adient (ADNT) increased its share repurchase authorization by $400M, bringing the total to $1B, with $435M remaining. The company also adopted a Tax Benefits Preservation Plan to protect its U.S. tax attributes, valued at $3.5B, which could reduce future cash tax payments. The plan aims to prevent unintended ownership changes that could limit the use of these tax benefits. According to the company, these moves reflect confidence in its business outlook and commitment to shareholder value.